X-LINKED HYPOPHOSPHATEMIA
Clinical trials for X-LINKED HYPOPHOSPHATEMIA explained in plain language.
Never miss a new study
Get alerted when new X-LINKED HYPOPHOSPHATEMIA trials appear
Sign up with your email to follow new studies for X-LINKED HYPOPHOSPHATEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
XLH study: watching the disease, not curing it
Knowledge-focused OngoingThis observational study follows 782 people with X-linked hypophosphatemia (XLH), a rare genetic bone disease, to understand how the condition changes over time. It also monitors the long-term safety and effectiveness of the drug burosumab. No new treatment is given; participants…
Matched conditions: X-LINKED HYPOPHOSPHATEMIA
Sponsor: Ultragenyx Pharmaceutical Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
XLH patients observed for a decade to uncover disease secrets
Knowledge-focused OngoingThis study follows 226 people with X-linked hypophosphatemia (XLH) for up to 10 years. Researchers will collect data on height, walking ability, fractures, and overall health to better understand how the disease progresses and affects daily life. No new treatment is being tested;…
Matched conditions: X-LINKED HYPOPHOSPHATEMIA
Sponsor: Kyowa Kirin Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:22 UTC